BOULDER, Colo. & NEW YORK--(BUSINESS WIRE)-- Infleqtion, a global leader in neutral-atom–based quantum technology, and Churchill Capital Corp X ( CCCX ) , a publicly traded special purpose acquisition company, today announced the confidential submission of a draft registration statement on Form S-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) on October 29, 2025. The submission...

Overview * Astronics ( ATRO ) Q3 sales up 3.8% to $211.4 mln, missing analyst expectations * Company reports Q3 net loss of $11.1 mln due to refinancing-related charges * Adjusted EBITDA for Q3 was $32.7 mln, or 15.5% of sales Outlook * Company expects Q4 revenue between $225 mln and $235 mln * Astronics ( ATRO ) sees 2025...

Overview * Equitable Holdings ( EQH ) reports Q3 net loss of $1.3 bln due to life reinsurance impact * Adjusted EPS for Q3 misses analyst expectations * Assets under management rose 7% yr/yr to $1.1 trillion Outlook * Equitable Holdings ( EQH ) maintains confidence in achieving 2027 financial targets * Company plans $1.5 bln capital deployment for growth...

Overview * Niagen Bioscience ( NAGE ) Q3 net sales rise 33%, beating analyst expectations * Adjusted EBITDA for Q3 increases 120%, reflecting improved operational performance * Company reaffirms full-year net sales growth outlook of 25% to 30% Outlook * Niagen Bioscience ( NAGE ) reaffirms 2025 net sales growth of 25% to 30% y-o-y * Company expects 2025 gross...